TRANSPLANTATION CD24 hi CD27 1 and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
暂无分享,去创建一个
M. Robin | M. Rybojad | R. Itzykson | M. Bagot | G. Socié | Anne Bergeron | V. Dessirier | A. Bensussan | N. Dhédin | N. Parquet | A. O'meara | D. Michonneau | R. Latour | J. Bouaziz | J. Monfort | D. Bengoufa | E. Hau | M. Branchtein | A. Xhaard | A. Masson | F. Fontbrune | H. L. Buanec | H. Buanec | N. Dhedin
[1] A. ElGhammaz. Current issues in chronic graft versus host disease , 2015 .
[2] K. Takeda,et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. , 2014, Immunity.
[3] K. Rezvani,et al. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. , 2014, Blood.
[4] J. Jagdeo,et al. Treatment of chronic graft-versus-host disease with bortezomib. , 2014, Blood.
[5] H. Li,et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10 , 2014, Leukemia.
[6] D. Hafler,et al. TLR‐mediated STAT3 and ERK activation controls IL‐10 secretion by human B cells , 2014, European journal of immunology.
[7] J. Byrd,et al. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. , 2014, Blood.
[8] V. D. Dang,et al. From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. , 2014, Current opinion in immunology.
[9] Hyun-Dong Chang,et al. Autocrine IL‐10 promotes human B‐cell differentiation into IgM‐ or IgG‐secreting plasmablasts , 2014, European journal of immunology.
[10] Ellen Hilgenberg,et al. B‐type suppression: A role played by “regulatory B cells” or “regulatory plasma cells”? , 2014, European journal of immunology.
[11] J. Serody,et al. Increased BCR responsiveness in B cells from patients with chronic GVHD. , 2014, Blood.
[12] J. Casanova,et al. IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts. , 2013, Blood.
[13] J. Casanova,et al. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells , 2013, The Journal of experimental medicine.
[14] A. Campos-Caro,et al. STAT-3 Activation by Differential Cytokines Is Critical for Human In Vivo–Generated Plasma Cell Survival and Ig Secretion , 2013, The Journal of Immunology.
[15] T. Huizinga,et al. IL-21 Enhances the Activity of the TLR–MyD88–STAT3 Pathway but Not the Classical TLR–MyD88–NF-κB Pathway in Human B Cells To Boost Antibody Production , 2013, The Journal of Immunology.
[16] J. Ritz,et al. Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial. , 2013, Blood.
[17] P. van Paassen,et al. Regulatory B cells in ANCA-associated vasculitis , 2013, Annals of the rheumatic diseases.
[18] J. Ritz,et al. Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease , 2013, Science Translational Medicine.
[19] Xiao-jun Huang,et al. Donor Th17 cells and IL‐21 may contribute to the development of chronic graft‐versus‐host disease after allogeneic transplantation , 2013, European journal of immunology.
[20] D. Isenberg,et al. CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation , 2013, Science Translational Medicine.
[21] J. Bussel,et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. , 2012, Blood.
[22] J. Ritz,et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. , 2012, Blood.
[23] W. Leonard,et al. Regulatory B Cells Control T Cell Autoimmunity Through IL-21-Dependent Cognate Interactions , 2012, Nature.
[24] V. Pascual,et al. Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation , 2012, The Journal of experimental medicine.
[25] C. Weaver,et al. Regulatory B10 Cells Differentiate into Antibody-Secreting Cells After Transient IL-10 Production In Vivo , 2012, The Journal of Immunology.
[26] S. Dillon,et al. Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. , 2012, Blood.
[27] P. Taylor,et al. Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. , 2011, Blood.
[28] J. Ritz,et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. , 2011, The New England journal of medicine.
[29] P. Youinou,et al. Human T cells induce their own regulation through activation of B cells. , 2011, Journal of autoimmunity.
[30] B. Falini,et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.
[31] W. Pickl,et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. , 2011, Blood.
[32] G. Socié. Chronic GVHD: B cells come of age. , 2011, Blood.
[33] J. Ritz,et al. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. , 2011, Blood.
[34] T. Rothstein,et al. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of Experimental Medicine.
[35] J. Wagner,et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.
[36] E. S. St. Clair,et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.
[37] M. Bagot,et al. IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro , 2010, European journal of immunology.
[38] M. Robin,et al. Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections , 2010, Haematologica.
[39] M. Jourdan,et al. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. , 2009, Blood.
[40] R. Storb,et al. The role of B cells in the pathogenesis of graft-versus-host disease. , 2009, Blood.
[41] J. Ritz,et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. , 2009, Blood.
[42] A. Hagenbeek,et al. B-cell involvement in chronic graft-versus-host disease , 2008, Haematologica.
[43] I. Sanz,et al. Phenotypic and functional heterogeneity of human memory B cells. , 2008, Seminars in immunology.
[44] J. Ritz,et al. High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease , 2007, Clinical Cancer Research.
[45] S. Tangye,et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. , 2003, The Journal of clinical investigation.
[46] Antonio Lanzavecchia,et al. Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.
[47] K. Rajewsky,et al. Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.
[48] S. Tangye,et al. Identification of Functional Human Splenic Memory B Cells by Expression of CD148 and CD27 , 1998, The Journal of experimental medicine.
[49] D. Tarlinton,et al. Kinetics of establishing the memory B cell population as revealed by CD38 expression. , 1998, Journal of immunology.
[50] J. Banchereau,et al. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype , 1996, The Journal of experimental medicine.
[51] H. Smits,et al. Toll-like receptor ligation for the induction of regulatory B cells. , 2014, Methods in molecular biology.
[52] J. Bouaziz,et al. Purification and immunophenotypic characterization of human B cells with regulatory functions. , 2014, Methods in molecular biology.
[53] J. Ritz,et al. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. , 2012, Blood.
[54] Eren,et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.
[55] M. Turner,et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.